Critical Election Day Victories for Psychedelics Continue the Industry's Momentum
November 09 2020 - 8:30AM
InvestorsHub NewsWire
Key
psychedelic drug ballot initiatives pass in Oregon and Washington,
D.C. setting a bright future for mental health care in the
U.S.
LAS
VEGAS, NV -- November 9, 2020 -- InvestorsHub NewsWire
-- Global Trac Solutions, Inc. (OTCPink:
PSYC) (“Global” “PSYC” or the “Company”) applauds the
successful passage of two key psychedelic ballot initiatives in
Oregon and the nation’s capital following the November 3rd
election. These victories continues to highlight a critical and
ongoing shift in support of medicinal psychedelics in the
U.S.
Oregon’s
Measure 109, a Psilocybin Therapy Initiative, will allow for the
development of a state-regulated program for psilocybin-assisted
therapy aimed at treating those suffering from debilitating mental
health conditions such as depression, anxiety, PTSD, and
addiction.
In a
July 2020 interview with PSYC CEO David Flores, Sheri Eckert, one
of the chief petitioners behind Measure 109, explained that
“it’s important to create new options.” Eckert said psilocybin
assisted therapy can help. “This approach will bring a new tool for
mental health and wellness into the field of care, and we need this
because our current treatment options are not working for enough
people. For some, psilocybin therapy might even eliminate the need
for daily dosing of psych meds, and that’s good news, because the
goal is to heal, not to prescribe more
pills.”
“Congratulations to Tom and Sheri Eckert for the
tireless work they have put into Measure 109,” said Flores. “We are
honored to have had the opportunity to share the important mission
and message associated with Measure 109 through our Psychedelic Spotlight platform.”
Washington D.C.’s Initiative 81 decriminalizes
several plant and fungi-based psychedelic substances. And with this
passage, DC joins other cities including Denver, Oakland, and Santa
Cruz, Calif., and Ann Arbor, Mich., which have already
decriminalized plant and fungi-based
psychedelics.
“We here
at PSYC are quite encouraged with the passage of these ballot
initiatives and how they further demonstrate the very viable path
for the emergence of medicinal psychedelics as an industry,” Flores
said. “We look forward to continuing to serve as a voice and
resource for the advancement of medicinal psychedelics, helping to
develop and shape what we believe is materializing into one of the
most prominent and critical industries of our
time.”
About Global Trac Solutions, Inc.
(OTCPink:
PSYC)
At Global Trac Solutions we are
integrating media, creativity, and technology to develop and deploy
thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society’s most pressing
matters.
PSYC has expressed its intent and
commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA’s more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, investors are speculating that the psychedelic boom
could be bigger than that of cannabis. PSYC is your source for
current investment related news specific to psychedelic medicines
and cutting-edge research improving overall health, moving this
sector into the mainstream.
We believe in a forward-thinking
approach that embraces groundbreaking new technology and
innovations and through the vision of business development we
intend to continue to evolve into these unchartered territories as
the industry leaders of the future. We truly are the right TRAC to
follow.
Forward-Looking Statements
Disclaimer:
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In some cases, you can
identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19, that may cause our results, levels of activity,
performance or achievements to be materially different from the
information expressed or implied by the forward-looking statements
in this press release. This press release should be considered in
light of all filings of the Company that are disclosed on the OTC
Markets.com website.
Disclaimer: Global Trac
Solutions, Inc. does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so
responsibly.
Corporate
Contact:
Global Trac Solutions, Inc.
(PSYC)
www.globaltracsolutions.com
(702) 239-1919
psyc@globaltracsolutions.com
OTCPINK:
PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Mar 2024 to Apr 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Apr 2023 to Apr 2024